AR017652A1 - SPHEROIDS CONTAINING ONE OR VARIOUS ACTIVE PRINCIPLES EXCEPT TIAGABINE, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONNECT AND PROCEDURE FOR THE PREPARATION - Google Patents

SPHEROIDS CONTAINING ONE OR VARIOUS ACTIVE PRINCIPLES EXCEPT TIAGABINE, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONNECT AND PROCEDURE FOR THE PREPARATION

Info

Publication number
AR017652A1
AR017652A1 ARP980105922A AR017652A1 AR 017652 A1 AR017652 A1 AR 017652A1 AR P980105922 A ARP980105922 A AR P980105922A AR 017652 A1 AR017652 A1 AR 017652A1
Authority
AR
Argentina
Prior art keywords
preparation
procedure
spheroids
approximately
tiagabine
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714631A external-priority patent/FR2771291B1/en
Priority claimed from FR9714635A external-priority patent/FR2771292B1/en
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of AR017652A1 publication Critical patent/AR017652A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Forma galénica que se presenta bajo la forma de esferoides, que contienen uno o varios principios activos con excepcion de tiagabina, que comprende:un nucleo y/o una capa que recubre dicho nucleo que contiene por lo menos un excipiente termoplástico,cuya consistencia va de pastosa a semi-solida, a unatemperatura del orden de 20*C y cuya temperatura de fusion está comprendida entre aproximadamente 25*C y aproximadamente 100*C recubierto con: unapelícula liviana y deformable, a base de un material polimérico, en particular una película cuya temperatura de transicion vítrea es inferior a aproximadamente30*C, lo cual asegura, la proteccion o bien el enmascaramiento del gusto, o la liberacion modificado y controlada de uno o varios principios activos;procedimiento para la preparacion de dichos esferoides, preparaciones farmacéuticas en multipartículas tal como comprimidos que contienen estosesferoides y procedimientos para su preparacion. Estas preparaciones farmacéuticas están destinadasa liberar los esferoides que las mismas contienen, yse caracterizan por la ausencia de una alteracion del perfil de liberacion del o de los principios activos a continuacion de una eventual etapa decompresion.Galenic form that is presented in the form of spheroids, which contain one or more active ingredients with the exception of thiagabine, comprising: a core and / or a layer that covers said nucleus containing at least one thermoplastic excipient, whose consistency ranges from pasty to semi-solid, at a temperature of the order of 20 * C and whose melting temperature is between approximately 25 * C and approximately 100 * C coated with: a light and deformable film, based on a polymeric material, in particular a film whose glass transition temperature is less than approximately 30 * C, which ensures, the protection or masking of taste, or the modified and controlled release of one or more active ingredients; procedure for the preparation of said spheroids, pharmaceutical preparations in multiparticles such as tablets containing these spheroids and procedures for their preparation. These pharmaceutical preparations are intended to release the spheroids they contain, and are characterized by the absence of an alteration of the release profile of the active ingredient (s) following an eventual decompression stage.

ARP980105922 1997-11-21 1998-11-20 SPHEROIDS CONTAINING ONE OR VARIOUS ACTIVE PRINCIPLES EXCEPT TIAGABINE, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONNECT AND PROCEDURE FOR THE PREPARATION AR017652A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714631A FR2771291B1 (en) 1997-11-21 1997-11-21 SPHEROIDS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS
FR9714635A FR2771292B1 (en) 1997-11-21 1997-11-21 TIAGABINE-CONTAINING SPHEROIDS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
AR017652A1 true AR017652A1 (en) 2001-09-12

Family

ID=45606356

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105922 AR017652A1 (en) 1997-11-21 1998-11-20 SPHEROIDS CONTAINING ONE OR VARIOUS ACTIVE PRINCIPLES EXCEPT TIAGABINE, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONNECT AND PROCEDURE FOR THE PREPARATION

Country Status (1)

Country Link
AR (1) AR017652A1 (en)

Similar Documents

Publication Publication Date Title
AR006678A1 (en) DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION
ES2171268T3 (en) FORMULATIONS OF TRAMADOL OF MULTIPLE UNITS.
MEP90908A (en) Solid lipid formulati on
ES2191862T3 (en) LIQUID COMPOSITION INCLUDING AN HIV PROTEASE INHIBITOR AND A FATTY ACID OF C12-C18.
MX9102501A (en) METHANE SULFONAMIDE DERIVATIVES, FARDERIVED COMPOSITIONS OF METHANOSULFONAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURE FOR SMACEUTICS THAT CONTAIN THEM AND PROCEDURE FOR U PREPARATION. ITS PREPARATION.
ES2095432T3 (en) DERIVATIVES OF 2,4-TIAZOLIDIN-DIONA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BR0314356A (en) Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods using the same
ATE304368T1 (en) MEDICINAL PRODUCTS CONTAINING HERBAL PLANTS
UY26306A1 (en) COMPOSITION FOR ORAL DOSING, OF INSTANT DISSOLUTION
AR054782A2 (en) PHARMACEUTICAL COMPOSITIONS AND TABLETS CONTAINING IRBESARTAN IN COMBINATION WITH A DIURETIC
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
AR034691A1 (en) PHARMACEUTICAL COMPOSITIONS OF ORAL ADMINISTRATION, CONTAINING A GASTROINTESTINAL LIPASE INHIBITOR, THE MASTICABLE TABLET AND THE COOKIE THAT INCLUDES THEM
ES2194501T3 (en) DERIVATIVES OF AMIDINAS, ITS PREPARATION, ITS APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2052603T3 (en) DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
CO4290417A1 (en) NEW BENZOYLGUANIDINES AS MEDICINES AND THEIR PREPARATION.
MX9102353A (en) N, O-SULPHATES OF HEPAROSANES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINED IN THEM.
AR022358A1 (en) AN EPO COMPOSITION, A PROCEDURE FOR OBTAINING IT, A PHARMACEUTICAL PREPARATION CONTAINING IT AND A PROCEDURE TO INCREASE THE SPECIFIC ACTIVITIES OF AN EPO COMPOSITION
ES2075129T3 (en) PREPARATION OF GEL CONTAINING ESTROGEN.
AR003984A1 (en) ANTIPRURITICAL, COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS, PROCEDURE FOR ITS PREPARATION AND USE OF SUCH COMPOSITIONS TO OBTAIN A MEDICATION.
DE69920201D1 (en) COMPOSITIONS CONTAINING GLYCOLE DERIVATIVES, ALCOHOLS AND VITAMIN D
ITMI20061672A1 (en) FORMULATIONS OF ACETYLSALICYLIC ACID OR ITS DERIVATIVES IN SOFT CAPSULES, EXHIBITING HIGH STABILITY
BR0111678A (en) Medicinal compositions containing propenone derivatives
AR027360A1 (en) PHARMACEUTICAL COMPOSITION
ES2158496T3 (en) ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS.
ATE107853T1 (en) ORAL MEDICATION CONTAINING MELATONIN.

Legal Events

Date Code Title Description
FB Suspension of granting procedure